GETI B logo

Getinge AB (publ) Stock Price

OM:GETI B Community·SEK 63.2b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 20 Fair Values set on narratives written by author

GETI B Share Price Performance

SEK 232.00
42.85 (22.65%)
SEK 232.90
Fair Value
SEK 232.00
42.85 (22.65%)
0.4% undervalued intrinsic discount
SEK 232.90
Fair Value
Price SEK 232.00
AnalystConsensusTarget SEK 232.90
AnalystHighTarget SEK 270.00
AnalystLowTarget SEK 169.66

GETI B Community Narratives

·
Fair Value SEK 232.9 0.4% undervalued intrinsic discount

Advanced Digital Health And Infection Control Will Drive Future Markets

0users have liked this narrative
0users have commented on this narrative
8users have followed this narrative
·
Fair Value SEK 270 14.1% undervalued intrinsic discount

Aging Populations, Digital Health And Emerging Markets Will Spur Lifesaving Demand

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
·
Fair Value SEK 169.66 36.7% overvalued intrinsic discount

Rising Tariffs And Regulation Will Squeeze Margins

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
SEK 232.9
0.4% undervalued intrinsic discount
Revenue
5.13% p.a.
Profit Margin
9.45%
Future PE
20.01x
Price in 2029
SEK 276.24
SEK 169.66
36.7% overvalued intrinsic discount
Revenue
4.06% p.a.
Profit Margin
8.29%
Future PE
17.29x
Price in 2029
SEK 202.03

Trending Discussion

No trending discussion available.

Updated Narratives

GETI B logo

GETI B: Fair Value View Balances Q2 Momentum And Earnings Outlook

Fair Value: SEK 232.9 0.4% undervalued intrinsic discount
8 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
GETI B logo

GETI B: Higher Dividend And Launch Of New EVH Platform Will Support Confidence

Fair Value: SEK 270 14.1% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
GETI B logo

GETI B: Dividend And Product Rollout Will Still Leave P/E Elevated

Fair Value: SEK 169.66 36.7% overvalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Undervalued with excellent balance sheet and pays a dividend.

1 Risk
4 Rewards

Getinge AB (publ) Key Details

SEK 34.2b

Revenue

SEK 17.6b

Cost of Revenue

SEK 16.6b

Gross Profit

SEK 14.0b

Other Expenses

SEK 2.7b

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
Oct 21, 2026
9.82
48.60%
7.82%
30.6%
View Full Analysis

About GETI B

Founded
1904
Employees
11758
CEO
Mattias Perjos
WebsiteView website
www.getinge.com

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solutions. In addition, the company provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, vascular and cardiothoracic surgery equipment, peripheral stenting, OEM solutions, and beating heart surgery equipment; and operating room equipment, anesthesia, advanced patient monitoring, and operating room integration solutions. Further, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices, and patient flow management; and low temperature sterilization, biocontainment in vaccine production, terminal sterilization, sterile isolation technology, cleaning and sterilization, aseptic transfer, and large-scale cultivation. Additionally, the company provides bioreactor preparation solution, bioprocess development and optimization, labware cleaning and sterilization, biocontainment, and vivarium. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

Recent GETI B News & Updates

Analysis Article 7h

Getinge AB (publ) Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Shareholders of Getinge AB (publ) ( STO:GETI B ) will be pleased this week, given that the stock price is up 10% to...
Narrative Update Jul 20

GETI B: Fair Value View Balances Q2 Momentum And Earnings Outlook

Analysts have lifted their fair value estimate for Getinge from SEK 224.70 to SEK 232.90, citing updated discount rate and growth assumptions. These are consistent with the recent Kepler Cheuvreux price target increase from SEK 235 to SEK 260 and expectations for stronger earnings momentum into 2026.

Recent updates

No updates